Lampl, Christian
MaassenVanDenBrink, Antoinette
Deligianni, Christina I.
Gil-Gouveia, Raquel
Jassal, Tanvir
Sanchez-del-Rio, Margarita
Reuter, Uwe
Uluduz, Derya
Versijpt, Jan
Zeraatkar, Dena
Sacco, Simona
Article History
Received: 7 April 2023
Accepted: 10 May 2023
First Online: 19 May 2023
Declarations
:
: Dena Zeraatkar and Janvir Jassal report no conflict of interest.Christian Lampl has received consulting fees and honoraria for lectures/presentations from AbbVie/Allergan, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva. CL participated in clinical trials as the principal investigator for Eli Lilly. Intellectual Christian Lampl is president of the European Headache Federation and associate editor for The Journal of Headache and Pain.Jan Versijpt received personal fees and nonfinancial support from Teva, personal fees from Novartis and Lundbeck, and grants and nonfinancial support from Allergan/Abbvie. Jan Versijpt serves as a member of the Board of Directors in the European Headache Federation.Christina I Deligianni has received HIS research fellowship grant, scholarship from Hellenic society of Neurology. Christina I Deligianni serves as a member of the Board of Directors in the European Headache Federation.Raquel Gil-Gouveia reports honoraria for lectures/presentations from AbbVie/Allergan, Eli Lily, Lundbeck, Novartis, Teva, Organon, Pfizer; participated in clinical trials as the principal investigator for AMGEN, Novartis, Lundbeck. research grants from Novartis. Raquel Gil-Gouveia serves as a member of the Board of Directors in European Headache Federation.Antoinette MaassenVanDenBrink received honoraria, research and/or travel grants from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Satsuma and Teva as principal investigator. Intellectual Antoinette MaassenVanDenBrink is vice-president of the European Headache Federation and associate editor for The Journal of Headache and Pain.Margarita Sanchez-del-Rio has received consulting fees and honoraria for lectures/presentations from Eli Lily, Lundbeck, Novartis, Teva and Pfizer. Intellectual as Secretary of the European Headache Federation, Review Editor on the Editorial Board of Headache and Neurogenic Pain (specialty section of Frontiers in Neurology). Margarita Sanchez-del-Rio serves as a member of the Board of Directors in the European Headache Federation.Uwe Reuter has received consulting fees, research grants or fees for presentations from Abbie, Allegan, Amgen, Lilly, Lundbeck, Medscape, Novartis, Pfizer, StreaMedup, Teva and the German Government (BMBF). Uwe Reuter is treasurer of the European Headache Federation.Derya Uluduz receives honoraria from Allergan-Abbvie, TEVA; consulting fees and honoraria for lectures/presentations from Eli Lily, Novartis, Allergan/Abbvie and Neutec. participated in clinical trials as the sub-investigator for AMGEN, Novartis. Derya Uluduz serves as a member of the Board of Directors in the European Headache Federation.Simona Sacco reports personal fees as speaker or advisor for Abbott, Allergan-Abbvie, AstraZeneca, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva; research grants from Novartis and Uriach; fees for CME/education from Medscape and Neurodiem Ology Medical Education; Intellectual as president elect European Stroke Organisation, second vice president of the European Headache Federation, specialty chief editor in Headache and Neurogenic Pain for Frontiers in Neurology, associate editor for The Journal of Headache and Pain, assistant editor for Stroke.